Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

S. 735, the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025, would establish federal initiatives focused on sickle cell disease and related genetic blood disorders. The bill would likely authorize funding for medical research into these conditions, support surveillance and monitoring programs to track disease prevalence and outcomes, and expand prevention and treatment options for affected patients.

If enacted, this legislation could increase federal resources dedicated to understanding and combating sickle cell disease, which disproportionately affects African Americans and other populations. The bill may support research institutions, healthcare providers, and public health agencies working to improve patient care, develop new therapies, and enhance early detection and prevention strategies. Currently, the bill is in the early stages of the legislative process, having been introduced in the Senate in February 2025 and referred to committee for consideration.